Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 6/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 6/20 | 0.33 |
| ▸ | PPARA | Q07869 | 5/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | ARG1 | P05089 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8070687 | 0.94 | CYP4F2 (0.39) | ALDH1A1CYP4F2CYP4A11PPARAPPARG | |
| SCHEMBL26511430 | 0.81 | CYP4F2 (0.44) | ALDH1A1CYP4F2CYP4A11PPARATSHR | |
| SCHEMBL7932802 | 0.80 | PPARA (0.41) | ALDH1A1CYP4F2CYP4A11PPARATSHR | |
| SCHEMBL13391665 | 0.79 | CYP4F2 (0.37) | ALDH1A1CYP4F2CYP4A11TSHRCA2 | |
| SCHEMBL9555782 | 0.78 | ALDH1A1 (0.38) | ALDH1A1TSHRARG1ARG2 | |
| SCHEMBL22609458 | 0.78 | LMNA (0.38) | ALDH1A1CYP4F2CYP4A11PPARATSHR | |
| SCHEMBL25375152 | 0.76 | PPARA (0.35) | ALDH1A1CYP4F2CYP4A11PPARATSHR | |
| SCHEMBL15105911 | 0.76 | PPARA (0.35) | ALDH1A1CYP4F2CYP4A11PPARATSHR | |
| SCHEMBL12647301 | 0.76 | ALDH1A1 (0.32) | ALDH1A1CYP4F2CYP4A11PPARATSHR | |
| SCHEMBL9999063 | 0.74 | ALDH1A1 (0.35) | ALDH1A1TSHRARG1ARG2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12562411-B2 | Multi-cycle formation methods for secondary battery cells | VOLTAXPLORE INC. (CA) | 2026-02-24 | — | — | US | disclosed |
| US-20250108365-A1 | FUNCTIONALIZED POLYMER SEPARATOR MEMBRANE FOR MITIGATING TRANSITION METAL DISSOLUTION AND TRAPPING ACIDIC SPECIES | GM Global Technology Operations LLC (US) | 2025-04-03 | — | — | US | disclosed |
| WO-2024148426-A1 | MULTI-CYCLE FORMATION METHODS FOR SECONDARY BATTERY CELLS | VOLTAXPLORE INC. (CA) | 2024-07-18 | — | — | WO | disclosed |
| US-20240234841-A1 | MULTI-CYCLE FORMATION METHODS FOR SECONDARY BATTERY CELLS | VOLTAXPLORE INC. (CA) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12562411-B2 | Multi-cycle formation methods for secondary battery cells | CACNA2D3, CACNA2D1, CACNA2D2 | ALDH1A1 4348/4885CYP4F2 3808/4885CYP4A11 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.